ErbB2/neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells

Molecular and Cellular Biology

Volumn 22, Issue 7, 2002, Pages 2204-2219

  Muraoka, Rebecca S ^a   Lenferink, Anne E G ^a   Law, Brian ^a   Hamilton, Elizabeth ^a   Brantley, Dana M ^a   Roebuck, L Renee ^a   Arteaga, Carlos L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIN D1; CYCLINE; DNA; PROTEIN P27; RNA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; NULL CELL; ONCOGENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL DIVISION; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRY; GENE DELETION; GENE DOSAGE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; RECEPTOR, ERBB-2; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MURINAE;

EID: 0036124467     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.7.2204-2219.2002     Document Type: Article

References (65)

1. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1
2. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
3. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
4. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
5. Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis
6. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
7. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
8. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
9. New insights into the tumor suppression function of P27(kip1)
10. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells
11. Mammary gland oncogenes as indicators of pathways important in mammary gland development
12. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
13. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway
14. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation
15. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
16. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
17. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
18. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas
19. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice
20. Cyclin D1 and prognosis in human breast cancer
21. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
22. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
23. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
24. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1
25. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
26. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: Receptor overexpression does not determine growth dependency
27. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
28. Cyclin DI is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
29. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways
30. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice
31. D-type cyclin-dependent kinase activity in mammalian cells
32. The mammary gland: A unique organ for the study of development and tumorigenesis
33. Identification of G1 kinase activity for cdk6, a novel cyclin D partner
34. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
35. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function
36. Expression of hepatocyte growth factor-like protein is repressed by retinoic acid and enhanced by cyclic adenosine 3′,5′-monophosphate response element-binding protein (CREB)-binding protein (CBP)
37. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
38. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
39. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
40. The ErbB signaling network: Receptor heterodimerization in development and cancer
41. p27(Kip1): Regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer
42. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
43. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
44. The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy
45. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation
46. Cyclin E-CDK2 is a regulator of p27Kip1
47. Cancer cell cycles
48. CDK inhibitors: Positive and negative regulators of G1-phase progression
49. Inhibitors of mammalian G1 cyclin-dependent kinases
50. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
51. A specific role for cyclin D1 in mammary gland development
52. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors
53. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
54. Regulation of the cdk inhibitor p27 and its deregulation in cancer
55. Formation of p27-CDK complexes during the human mitotic cell cycle
56. p27/Kip1 mutation found in breast cancer
57. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
58. Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice
59. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
60. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
61. Regulation of the cell cycle machinery by oncogenic ras
62. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E
63. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27
64. Untangling the ErbB signalling network
65. Specific protection against breast cancers by cyclin D1 ablation